Over 2 years of follow up, patients with high AGP levels had lower MALE-free survival rates [mild (64% vs. 100%, p = 0.02), moderate (64% vs. 85%, p = 0.02), severe (55% vs. 88%, p = 0.02), all PAD (62% vs. 88%, p = 0.01)] (Figure 2). Here, ATP5MK is linked to peripheral arterial disease.